{"entity":{"type":"insider","cik":"0001639144","url":"/insider/0001639144","json_url":"/insider/0001639144.json","name":"Daruwala Paul","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":7,"first":"2019-03-08","last":"2022-09-13","span_basis":"filed_date"},"name_variants":[{"name":"Daruwala Paul","source":"filing","n_filings":7,"first_seen":"2019-03-08","last_seen":"2022-09-13"}],"transactions":[{"id":6732698,"accession":"0001610618-22-000076","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610618-22-000076","line_url":"/filing/0001610618-22-000076#line-1","is_derivative":false,"issuer_cik":"0001610618","issuer_name":"Cidara Therapeutics, Inc.","issuer_ticker":"CDTX","issuer_name_source":null,"issuer_url":"/issuer/0001610618","owner_cik":"0001639144","owner_name":"Daruwala Paul","owner_display_name":"Daruwala Paul","owner_url":"/insider/0001639144","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16199.0,"shares_display":"16,199","price_per_share":0.6849,"price_display":"0.68","price_state":"stated","total_value":11094.6951,"total_display":"11,094.70","total_whole":"11,095","shares_owned_after":221099.0,"shares_owned_after_display":"221,099","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-12","filed_date":"2022-09-13","scope":"insider"},{"id":6667813,"accession":"0001209191-22-002604","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-002604","line_url":"/filing/0001209191-22-002604#line-2","is_derivative":false,"issuer_cik":"0001610618","issuer_name":"Cidara Therapeutics, Inc.","issuer_ticker":"CDTX","issuer_name_source":null,"issuer_url":"/issuer/0001610618","owner_cik":"0001639144","owner_name":"Daruwala Paul","owner_display_name":"Daruwala Paul","owner_url":"/insider/0001639144","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5133.0,"shares_display":"5,133","price_per_share":1.25,"price_display":"1.25","price_state":"stated","total_value":6416.25,"total_display":"6,416.25","total_whole":"6,416","shares_owned_after":187298.0,"shares_owned_after_display":"187,298","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-05","filed_date":"2022-01-07","scope":"insider"},{"id":5010499,"accession":"0001610618-21-000031","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001610618-21-000031","line_url":"/filing/0001610618-21-000031#line-3","is_derivative":false,"issuer_cik":"0001610618","issuer_name":"Cidara Therapeutics, Inc.","issuer_ticker":"CDTX","issuer_name_source":null,"issuer_url":"/issuer/0001610618","owner_cik":"0001639144","owner_name":"Daruwala Paul","owner_display_name":"Daruwala Paul","owner_url":"/insider/0001639144","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":593.0,"shares_display":"593","price_per_share":2.66,"price_display":"2.66","price_state":"stated","total_value":1577.38,"total_display":"1,577.38","total_whole":"1,577","shares_owned_after":50531.0,"shares_owned_after_display":"50,531","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-01","filed_date":"2021-04-05","scope":"insider"},{"id":5010495,"accession":"0001610618-21-000031","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610618-21-000031","line_url":"/filing/0001610618-21-000031#line-1","is_derivative":false,"issuer_cik":"0001610618","issuer_name":"Cidara Therapeutics, Inc.","issuer_ticker":"CDTX","issuer_name_source":null,"issuer_url":"/issuer/0001610618","owner_cik":"0001639144","owner_name":"Daruwala Paul","owner_display_name":"Daruwala Paul","owner_url":"/insider/0001639144","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2868.0,"shares_display":"2,868","price_per_share":2.06,"price_display":"2.06","price_state":"stated","total_value":5908.08,"total_display":"5,908.08","total_whole":"5,908","shares_owned_after":49724.0,"shares_owned_after_display":"49,724","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-05","filed_date":"2021-04-05","scope":"insider"},{"id":9271202,"accession":"0001209191-20-039024","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-039024","line_url":"/filing/0001209191-20-039024#line-1","is_derivative":false,"issuer_cik":"0001639144","issuer_name":"Cidara Therapeutics, Inc.","issuer_ticker":"CDTX","issuer_name_source":null,"issuer_url":"/issuer/0001639144","owner_cik":"0001639144","owner_name":"Daruwala Paul","owner_display_name":"Daruwala Paul","owner_url":"/insider/0001639144","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":940.0,"shares_display":"940","price_per_share":3.42,"price_display":"3.42","price_state":"stated","total_value":3214.8,"total_display":"3,214.80","total_whole":"3,215","shares_owned_after":52592.0,"shares_owned_after_display":"52,592","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-03","filed_date":"2020-06-25","scope":"insider"},{"id":2576410,"accession":"0001209191-20-002030","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-002030","line_url":"/filing/0001209191-20-002030#line-1","is_derivative":false,"issuer_cik":"0001610618","issuer_name":"Cidara Therapeutics, Inc.","issuer_ticker":"CDTX","issuer_name_source":null,"issuer_url":"/issuer/0001610618","owner_cik":"0001639144","owner_name":"Daruwala Paul","owner_display_name":"Daruwala Paul","owner_url":"/insider/0001639144","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2340.0,"shares_display":"2,340","price_per_share":3.42,"price_display":"3.42","price_state":"stated","total_value":8002.8,"total_display":"8,002.80","total_whole":"8,003","shares_owned_after":53532.0,"shares_owned_after_display":"53,532","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-03","filed_date":"2020-01-06","scope":"insider"},{"id":8601209,"accession":"0001209191-19-052480","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-052480","line_url":"/filing/0001209191-19-052480#line-1","is_derivative":false,"issuer_cik":"0001610618","issuer_name":"Cidara Therapeutics, Inc.","issuer_ticker":"CDTX","issuer_name_source":null,"issuer_url":"/issuer/0001610618","owner_cik":"0001639144","owner_name":"Daruwala Paul","owner_display_name":"Daruwala Paul","owner_url":"/insider/0001639144","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3295.0,"shares_display":"3,295","price_per_share":1.88,"price_display":"1.88","price_state":"stated","total_value":6194.6,"total_display":"6,194.60","total_whole":"6,195","shares_owned_after":55872.0,"shares_owned_after_display":"55,872","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-02","filed_date":"2019-10-03","scope":"insider"},{"id":8754022,"accession":"0001209191-19-018293","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-018293","line_url":"/filing/0001209191-19-018293#line-1","is_derivative":false,"issuer_cik":"0001610618","issuer_name":"Cidara Therapeutics, Inc.","issuer_ticker":"CDTX","issuer_name_source":null,"issuer_url":"/issuer/0001610618","owner_cik":"0001639144","owner_name":"Daruwala Paul","owner_display_name":"Daruwala Paul","owner_url":"/insider/0001639144","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2240.0,"shares_display":"2,240","price_per_share":2.5507,"price_display":"2.55","price_state":"stated","total_value":5713.568,"total_display":"5,713.57","total_whole":"5,714","shares_owned_after":49567.0,"shares_owned_after_display":"49,567","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-07","filed_date":"2019-03-08","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001610618","name":"Cidara Therapeutics, Inc.","url":"/issuer/0001610618","role":"Officer (Chief Operating Officer)","n_filings":7,"first_seen":"2019-03-08","last_seen":"2022-09-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001639144","retrieved_at":"2026-08-27T03:06:54+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}